We are investigating whether tasimelteon can help people with Delayed Sleep-Wake Phase Disorder fall asleep faster and improve their overall sleep quality compared to a placebo.
Health conditions and diseases that the clinical trial is designed to study and treat.
Delayed Sleep-Wake Phase Disorder (DSWPD) is a condition where a person's sleep is delayed by two or more hours beyond the conventional bedtime, leading to difficulty waking up in the morning and often resulting in daytime sleepiness.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
